火针加拔罐治疗急性带状疱疹:随机对照试验研究方案
本研究为三臂随机平行对照试验方案,拟纳入105例急性带状疱疹伴疼痛患者,等比例分为火针加拔罐组、泛昔洛韦加加巴喷丁组及火针加拔罐加泛昔洛韦组,干预1周,主要结局为视觉模拟量表评价疼痛缓解,次要结局包括血浆P物质和β-内啡肽浓度变化及症状体征等。
要点
- 火针加拔罐在中国广泛用于急性带状疱疹止痛,但缺乏严格随机对照试验验证。
- 试验设三组:火针加拔罐、泛昔洛韦加加巴喷丁、火针加拔罐加泛昔洛韦。
- 主要结局为视觉模拟量表疼痛强度缓解,随访带状疱疹后神经痛。
核心结论
- 该试验旨在为火针加拔罐治疗急性带状疱疹提供优于泛昔洛韦加加巴喷丁及联合治疗的充分证据。
- 结果可能为减少急性疼痛和治愈急性带状疱疹感染提供可信的替代疗法。
研究设计与样本
- 三臂随机平行对照试验方案,共纳入105例急性带状疱疹伴疼痛患者,等比例随机分为三组。
- A组火针加拔罐:1周内每天1次,共7次治疗;B组泛昔洛韦加加巴喷丁:1周内每日口服3次;C组联合A组和B组治疗。
- 试验期间若出现突发不可耐受疼痛,可谨慎给予镇痛药物临时缓解。
- 主要结局采用视觉模拟量表评估疼痛强度缓解;次要结局包括外周血浆P物质和β-内啡肽浓度变化、镇痛需求、副作用、症状和体征。
- 随访参与者带状疱疹后神经痛发生情况。
关键数值与推荐
- 主要结局指标为视觉模拟量表评估的疼痛强度缓解。
- 次要结局包括外周血浆P物质和β-内啡肽浓度变化。
- 次要结局还包括镇痛需求、副作用、疼痛分类、局部瘙痒、烧灼感、发热、局部淋巴结肿大、皮损面积、水疱、疱疹簇、水疱特征、溃疡和丘疹。
临床怎么用
- 若试验证实有效,火针加拔罐可作为急性带状疱疹急性疼痛的替代治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute herpes zoster (AHZ) is a common skin disease caused by invasion of the varicella zoster virus into the ganglia and skin, and the severe pain is the most complaint, which can seriously disturb the normal life of patients. Fire needle plus cupping is a special acupuncture treatment, which is widely used to treat AHZ for its better analgesic effect in China although it has not been fully verified by rigorous randomized controlled trial (RCT). METHODS/DESIGN: To test the effect, a three-arm randomized parallel controlled trial protocol has been designed. A total of 105 AHZ patients suffering pain will be randomly divided into three groups in an equal proportion. The interventions are fire needle plus cupping (FC) in group A, famciclovir plus gabapentin (FG) in group B, and fire needle plus cupping plus famciclovir (FCF) in group C. The length for the trial is set for a week time frame. Precisely speaking, the A group (FC) is to carry out 1 treatment per day for the total of 7 treatment sessions within 1 week period. On the other hand, the B group (FG) will take drugs orally three times a day within the trial 1 week. Meanwhile, with its combination element, the C group (FCF) is due to undertake both treatments and drugs as prescribed for A and B groups within the trial week. As an intra-trial arrangement, analgesic medication will be carefully administered for temporary pain release if the sudden intolerable pain appeared. For the primary outcome, this study is due to apply visual analogue scale to identify pain intensity relief. As the secondary outcomes are concerned, this study is aiming to focus on the issues related to changes in substance P and beta-endorphin concentrations in peripheral plasma, as well as those issues of analgesic needs, side effects, symptoms, and physical signs including pain classification, local itching, burning sensation, fever, local lymphadenopathy, skin lesion area, blisters, herpes clusters, vesicular traits, ulcers, and pimples; all these are taken into account for evaluation. For the final stage, the participants are to be followed up for postherpetic neuralgia. DISCUSSION: The results of this trial aim to provide sufficient evidence on FC treatment over both FG and FCF treatments. It will then give a credible alternative treatment to cut down acute pain and to cure AHZ infection. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1800015372 . Registered on 28 March 2018.
引用
- Zhang Y, Liang Z, Li S, et al. Fire needle plus cupping for acute herpes zoster: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32762718. doi:10.1186/s13063-020-04599-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。